Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

THZ-1

SKU: orb1226067

Description

A potent, selective, covalent CDK7 inhibitor with IC50 of 3.2 nM; also weakly inhibits CDK12 with IC50 of 250 nM; displays broad-based activity a subset of cancer cell lines with IC50s of <200 nM; causes decreased cellular proliferation and an increase in apoptotic index (MCL-1, XIAP), disproportionally affects transcription of RUNX1 in Jurkat T-ALL cells; demonstrates efficacy against primary leukemia cells and in a bioluminescent xenografted model at 10mg/kg.

Images & Validation

Key Properties

CAS Number1604810-83-4
MW566.0527
Purity>98% (HPLC)
FormulaC31H28ClN7O2
SMILESCN(C)CC=CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl
TargetCDK
SolubilityDMSO: ≥ 27 mg/mL

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

CDK7 inhibitor

Similar Products

  • (E/Z)-THZ1 2HCl [orb1304110]

    99.51% (May vary between batches)

    2095433-94-4

    638.98

    C31H30Cl3N7O2

    50 mg, 1 mg, 5 mg, 10 mg, 25 mg, 100 mg, 200 mg
  • THZ1 [orb1303940]

    >97%

    1604810-83-4

    566.05

    C31H28ClN7O2

    5 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

200 mg
500 mg
5 mg
$ 140.00
10 mg
$ 230.00
25 mg
$ 390.00
50 mg
$ 580.00
100 mg
$ 780.00